Journal
CELL AND TISSUE BANKING
Volume 24, Issue 1, Pages 1-9Publisher
SPRINGER
DOI: 10.1007/s10561-022-10028-2
Keywords
Cell- and tissue-based therapy; Marketing of health services; Regenerative medicine
Categories
Ask authors/readers for more resources
The field of regenerative medicine has the potential to impact the healthcare system by replacing or restoring lost cells in the human body. However, its proficiency in clinical trials has been disappointing. Therefore, establishing a safe and efficient infrastructure framework is crucial for the progress of regenerative medicine.
The field of regenerative medicine (RM) as an innovative technology has the ability to affect the healthcare system. It develops a variety of techniques through stem cell biology, genetics, bioengineering, biomaterial science, and tissue engineering to replace or restore the role of lost, disabled, or aging cells in the human body. However, the field's proficiency has still been underwhelming at the clinical trial level. This could be due to the innovation of such technologies, as well as their incredible nature. Therefore, managing the infrastructure framework for the safe and efficient application of the aforementioned field of science would help in the process of progress. In this context, the current review focuses on how to establish infrastructures for more effective RM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available